Assembly Biosciences, Inc. (ASMB) vs ARS Pharmaceuticals, Inc. (SPRY)
- Assembly Biosciences, Inc. ASMB 20.09 −2.33%
- ARS Pharmaceuticals, Inc. SPRY 4.02 −1.23%
Assembly Biosciences, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($418.8M and $404.8M). ARS Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 19.7×. Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against 4.08%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −184.3%) and the higher return on invested capital (0.00% vs −335.7%). Across the 17 metrics below, Assembly Biosciences, Inc. leads on 15 and ARS Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | ASMB | SPRY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 71.37% | 65.16% |
| Operating margin | (11.75%) | (184.96%) | 0.00% |
| Net margin | (0.06%) | (184.26%) | 0.00% |
| Free cash flow margin | (51.53%) | (167.97%) | 0.00% |
| Return on equity | (0.03%) | (210.37%) | (56.36%) |
| Return on assets | (0.02%) | (76.54%) | (48.04%) |
| Return on invested capital | 0.00% | (335.65%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack